{"id":504,"date":"2022-05-16T06:13:10","date_gmt":"2022-05-16T06:13:10","guid":{"rendered":"https:\/\/www.sweepstakesbible.com\/blog\/?p=504"},"modified":"2023-01-09T05:38:14","modified_gmt":"2023-01-09T05:38:14","slug":"264m-epipen-antitrust-class-action-settlement-epipenclassaction-com","status":"publish","type":"post","link":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/","title":{"rendered":"$264M EpiPen Antitrust Class Action Settlement"},"content":{"rendered":"<p>A class-action lawsuit has been brought against Mylan alleging the company of associating with Pfizer and other companies to increase the cost of the EpiPen. These epinephrine injectors can save people from life-threatening allergic reactions. While Mylan, a Vitaris company manufactures the branded variant of Epipen, there are also authorized generics available in the market. A 2017 class-action lawsuit alleged Mylan of working with Pfizer to raise the price of the life-saving EpiPen products. According to the plaintiffs, the companies violated various racketeering and <a href=\"https:\/\/www.sweepstakesbible.com\/blog\/tags\/antitrust-settlements\/\" target=\"_blank\" rel=\"noopener\">antitrust<\/a> laws through their scheme. The Mylan EpiPen class-action lawsuit contends that the defendants came up with an illegal scheme for monopolizing the market with its epinephrine autoinjector devices.<\/p>\n<p>This caused millions of Americans to shell out exorbitant prices for EpiPens which aren\u2019t constrained by or tethered to a competitive market. Mylan allegedly hiked the price of EpiPens by more than 600% in 2016 from $100 in 2007 to $608 in 2016. Plaintiffs blamed this antitrust agreement of Mylan with Pfizer for being driven solely by unaccountable companies and executives who tried to profit off human fear and misery. Mylan allegedly misclassified EpiPens under Medicaid\u2019s rebate program in support of its scheme. They also engaged in restrained competition, and deceptive marketing and used invalid patents for blocking generics. These actions brought about a 2017 investigation by the Federal Trade Commission. Though Mylan has not admitted any wrongdoing, it has agreed to resolve all allegations brought against them with a $264 million settlement. On getting the approval of the court, this <a href=\"https:\/\/www.sweepstakesbible.com\/blog\/category\/settlement\/\" target=\"_blank\" rel=\"noopener\">settlement<\/a> fund shall be distributed among class members alongside any interest earned thereon after deducting any taxes and tax expenses, notice and administration expenses, litigation expenses, attorney\u2019s fees, and service awards to the Plaintiff Class representatives. Pfizer agreed to a similar settlement in 2021 by shelling out $345 million. Class Members who submitted a claim form with the Pfizer settlement in 2021 don\u2019t have to submit a claim as the same form will be used for disbursing payments under the Mylan settlement.<\/p>\n<p><strong>Eligibility For Making Claim: <\/strong>The terms of this settlement are expected to benefit entities and individuals who either provided or paid for reimbursement for either some or all of the purchase <a href=\"https:\/\/www.sweepstakesbible.com\/blog\/tags\/price-fixing-settlement\/\">price<\/a> of branded EpiPens or its authorized generic equivalents for consumption and not for resale by themselves, their family, insureds, employees, beneficiaries, or plain participants between 24<sup>th<\/sup> August 2011 and 1<sup>st<\/sup> November 2020 and did not exclude themselves from the Class during the initial notice period.<\/p>\n<p><strong>Proof Of Purchase:<\/strong> You don\u2019t need to submit anything else if a Proof Of Claim form was already submitted during the settlement with the Pfizer defendants in 2021 in this case. Otherwise, you will have to submit a proof of claim that is either submitted online or postmarked within 25<sup>th<\/sup> July 2022.<\/p>\n<p><strong>Potential Claim Amount:<\/strong> According to the settlement terms, Class Members are eligible to receive payments in either one of the two fund pools. The first fund constitutes 20% of the net settlement fund and is expected to benefit consumers who bought EpiPens. The second fund constituting the remaining 80% of the net settlement fund will benefit third-party payors like insurance companies who either reimbursed consumers or paid for EpiPens. The exact amount of payment will vary according to the number of valid claims filed in each pool.<\/p>\n<p><strong>Objection Deadline: <\/strong>8<sup>th<\/sup> June 2022 is the last date for objecting to the settlement, request for attorney\u2019s fees, expenses or service awards, and the Plan of Allocation.<\/p>\n<p><strong>Settlement Website: <\/strong>EpipenClassAction.com<strong><br \/>\n<\/strong><strong style=\"background-color: var(--global--color-background); color: var(--global--color-primary); font-family: var(--global--font-secondary); font-size: var(--global--font-size-base);\">Claim Form: <\/strong><a style=\"background-color: var(--global--color-background); font-family: var(--global--font-secondary); font-size: var(--global--font-size-base);\" href=\"https:\/\/www.epipenclassaction.com\/FileClaim\" target=\"_blank\" rel=\"noopener\">In re EpiPen Marketing, Sales Practices and Antitrust Litigation (epipenclassaction.com)<\/a><br \/>\n<strong>Deadline For Submitting Claim:\u00a0<\/strong>06\/25\/2022<br \/>\n<strong>Final Hearing Date: <\/strong>06\/06\/2022<br \/>\n<strong>Settlement Amount:<\/strong> $264 million<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A class-action lawsuit has been brought against Mylan alleging the company of associating with Pfizer and other companies to increase the cost of the EpiPen. These epinephrine injectors can save people from life-threatening allergic reactions. While Mylan, a Vitaris company manufactures the branded variant of Epipen, there are also authorized generics available in the market.&hellip; <a class=\"more-link\" href=\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\">Continue reading <span class=\"screen-reader-text\">$264M EpiPen Antitrust Class Action Settlement<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":505,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[28],"class_list":["post-504","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-settlement","tag-antitrust-settlements","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$264M EpiPen Antitrust Class Action Settlement - Sweepstakesbible Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$264M EpiPen Antitrust Class Action Settlement - Sweepstakesbible Blog\" \/>\n<meta property=\"og:description\" content=\"A class-action lawsuit has been brought against Mylan alleging the company of associating with Pfizer and other companies to increase the cost of the EpiPen. These epinephrine injectors can save people from life-threatening allergic reactions. While Mylan, a Vitaris company manufactures the branded variant of Epipen, there are also authorized generics available in the market.&hellip; Continue reading $264M EpiPen Antitrust Class Action Settlement\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Sweepstakesbible Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-16T06:13:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-09T05:38:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"442\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Penelope Envy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Penelope Envy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\"},\"author\":{\"name\":\"Penelope Envy\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/person\/5831d8efedd296dcb39f915fa2b68560\"},\"headline\":\"$264M EpiPen Antitrust Class Action Settlement\",\"datePublished\":\"2022-05-16T06:13:10+00:00\",\"dateModified\":\"2023-01-09T05:38:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\"},\"wordCount\":599,\"publisher\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg\",\"keywords\":[\"Antitrust Litigation Settlements 2023\"],\"articleSection\":[\"Settlement\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\",\"url\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\",\"name\":\"$264M EpiPen Antitrust Class Action Settlement - Sweepstakesbible Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg\",\"datePublished\":\"2022-05-16T06:13:10+00:00\",\"dateModified\":\"2023-01-09T05:38:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage\",\"url\":\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg\",\"contentUrl\":\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg\",\"width\":700,\"height\":442,\"caption\":\"EpiPen Antitrust Class Action Settlement on EpipenClassAction.com\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sweepstakesbible.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$264M EpiPen Antitrust Class Action Settlement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#website\",\"url\":\"https:\/\/www.sweepstakesbible.com\/blog\/\",\"name\":\"Sweepstakesbible Blog\",\"description\":\"Money Always Matters\",\"publisher\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sweepstakesbible.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#organization\",\"name\":\"SweepstakesBible\",\"url\":\"https:\/\/www.sweepstakesbible.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2021\/09\/logo1.png\",\"contentUrl\":\"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2021\/09\/logo1.png\",\"width\":422,\"height\":84,\"caption\":\"SweepstakesBible\"},\"image\":{\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/person\/5831d8efedd296dcb39f915fa2b68560\",\"name\":\"Penelope Envy\",\"description\":\"I have been successful probably because I have always realized that I knew nothing about writing and have merely tried to tell an interesting story entertainingly. At the end of the day your ability to connect with your readers comes down to how you make them feel.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$264M EpiPen Antitrust Class Action Settlement - Sweepstakesbible Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/","og_locale":"en_US","og_type":"article","og_title":"$264M EpiPen Antitrust Class Action Settlement - Sweepstakesbible Blog","og_description":"A class-action lawsuit has been brought against Mylan alleging the company of associating with Pfizer and other companies to increase the cost of the EpiPen. These epinephrine injectors can save people from life-threatening allergic reactions. While Mylan, a Vitaris company manufactures the branded variant of Epipen, there are also authorized generics available in the market.&hellip; Continue reading $264M EpiPen Antitrust Class Action Settlement","og_url":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/","og_site_name":"Sweepstakesbible Blog","article_published_time":"2022-05-16T06:13:10+00:00","article_modified_time":"2023-01-09T05:38:14+00:00","og_image":[{"width":700,"height":442,"url":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg","type":"image\/jpeg"}],"author":"Penelope Envy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Penelope Envy","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#article","isPartOf":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/"},"author":{"name":"Penelope Envy","@id":"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/person\/5831d8efedd296dcb39f915fa2b68560"},"headline":"$264M EpiPen Antitrust Class Action Settlement","datePublished":"2022-05-16T06:13:10+00:00","dateModified":"2023-01-09T05:38:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/"},"wordCount":599,"publisher":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg","keywords":["Antitrust Litigation Settlements 2023"],"articleSection":["Settlement"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/","url":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/","name":"$264M EpiPen Antitrust Class Action Settlement - Sweepstakesbible Blog","isPartOf":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage"},"image":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg","datePublished":"2022-05-16T06:13:10+00:00","dateModified":"2023-01-09T05:38:14+00:00","breadcrumb":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#primaryimage","url":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg","contentUrl":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2022\/05\/epipenclassaction.jpg","width":700,"height":442,"caption":"EpiPen Antitrust Class Action Settlement on EpipenClassAction.com"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sweepstakesbible.com\/blog\/settlement\/264m-epipen-antitrust-class-action-settlement-epipenclassaction-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sweepstakesbible.com\/blog\/"},{"@type":"ListItem","position":2,"name":"$264M EpiPen Antitrust Class Action Settlement"}]},{"@type":"WebSite","@id":"https:\/\/www.sweepstakesbible.com\/blog\/#website","url":"https:\/\/www.sweepstakesbible.com\/blog\/","name":"Sweepstakesbible Blog","description":"Money Always Matters","publisher":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sweepstakesbible.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.sweepstakesbible.com\/blog\/#organization","name":"SweepstakesBible","url":"https:\/\/www.sweepstakesbible.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2021\/09\/logo1.png","contentUrl":"https:\/\/www.sweepstakesbible.com\/blog\/wp-content\/uploads\/2021\/09\/logo1.png","width":422,"height":84,"caption":"SweepstakesBible"},"image":{"@id":"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sweepstakesbible.com\/blog\/#\/schema\/person\/5831d8efedd296dcb39f915fa2b68560","name":"Penelope Envy","description":"I have been successful probably because I have always realized that I knew nothing about writing and have merely tried to tell an interesting story entertainingly. At the end of the day your ability to connect with your readers comes down to how you make them feel."}]}},"_links":{"self":[{"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/posts\/504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/comments?post=504"}],"version-history":[{"count":6,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/posts\/504\/revisions"}],"predecessor-version":[{"id":1152,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/posts\/504\/revisions\/1152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/media\/505"}],"wp:attachment":[{"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/media?parent=504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/categories?post=504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sweepstakesbible.com\/blog\/wp-json\/wp\/v2\/tags?post=504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}